With the combined expertise of founders John Ramunas and Glenn Markov, Rejuvenation Technologies is developing RTI-IMM for an undisclosed condition of the immune system. The company’s dedication lies in addressing telomere attrition, a central mechanism behind aging.
×
Rejuvenation Technologies � RTI-IMM (NA2)
© 2021 - Lifespan Extension Advocacy Foundation - LIFESPAN2023
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.
Powered by MMD